This document provides a 5-step guide for getting started with medical cannabis. The steps are: 1) identify the primary symptom to treat, 2) determine your budget, 3) choose an appropriate delivery method such as inhalation, tinctures, or edibles, 4) select a product containing THC, CBD, or a combination, and 5) determine your starting serving size, beginning with 2.5mg of THC or less for beginners. Safety considerations and sources for further information are also outlined.
The document provides training objectives and information for Approved Medication Assistive Personnel (AMAP) on medication procedures, including ensuring the "six rights" of medication administration, different medication types and routes of administration, infection control practices like hand washing, and the importance of proper documentation. The goals are to give AMAP trainees an understanding of commonly prescribed medications and safe, legal practices for medication handling and administration.
This document summarizes a presentation about managing medications effectively. The objectives covered include understanding why medications are prescribed, improving adherence, developing management strategies, and maintaining an up-to-date medication list. Key points discussed include the importance of medication adherence for health outcomes, the high costs associated with non-adherence, and strategies to improve adherence such as pill boxes, reminders, and understanding dosing instructions. The presentation emphasizes consulting pharmacists for any medication questions or concerns.
pediatric procedural sedation is for young EM doctors and anesthetists and pediatricians. When painful procedures can be managed with minimal to no pain-- why not???
poorly managed pain- leads to PTSD in kids--- would we want that for our kids?
It is important for patients to understand their medications by reading the provided leaflet. The leaflet explains why the medication was prescribed, how to take it properly, potential side effects, drug interactions, and storage instructions. Understanding dosage times, adverse reactions, and duration of effects allows patients to take medications safely and get the full benefits. The references provide additional resources on medication safety.
This document discusses pain assessment and management. It provides an overview of different pain scales used to assess intensity, location, quality and other factors. It reviews opioid pharmacology including delivery methods, side effects like constipation and nausea/vomiting, and challenges to pain management like barriers to treatment. Common chronic pain syndromes like cancer, low back pain and osteoarthritis are examined in terms of characteristics, diagnosis and treatment considerations.
Is CBD addictive? Does it make you high? To put it short — no, CBD is not addictive. But let's dig deeper and learn why in our recent research. We look at the scientific proof of why CBD is not addictive. And the legislative point of view, which is also backed up by science. In our article, you can learn about the nature of addiction, and understand why we crave some things more than others. Take a look!
The document provides training objectives and information for Approved Medication Assistive Personnel (AMAP) on medication procedures, including ensuring the "six rights" of medication administration, different medication types and routes of administration, infection control practices like hand washing, and the importance of proper documentation. The goals are to give AMAP trainees an understanding of commonly prescribed medications and safe, legal practices for medication handling and administration.
This document summarizes a presentation about managing medications effectively. The objectives covered include understanding why medications are prescribed, improving adherence, developing management strategies, and maintaining an up-to-date medication list. Key points discussed include the importance of medication adherence for health outcomes, the high costs associated with non-adherence, and strategies to improve adherence such as pill boxes, reminders, and understanding dosing instructions. The presentation emphasizes consulting pharmacists for any medication questions or concerns.
pediatric procedural sedation is for young EM doctors and anesthetists and pediatricians. When painful procedures can be managed with minimal to no pain-- why not???
poorly managed pain- leads to PTSD in kids--- would we want that for our kids?
It is important for patients to understand their medications by reading the provided leaflet. The leaflet explains why the medication was prescribed, how to take it properly, potential side effects, drug interactions, and storage instructions. Understanding dosage times, adverse reactions, and duration of effects allows patients to take medications safely and get the full benefits. The references provide additional resources on medication safety.
This document discusses pain assessment and management. It provides an overview of different pain scales used to assess intensity, location, quality and other factors. It reviews opioid pharmacology including delivery methods, side effects like constipation and nausea/vomiting, and challenges to pain management like barriers to treatment. Common chronic pain syndromes like cancer, low back pain and osteoarthritis are examined in terms of characteristics, diagnosis and treatment considerations.
Is CBD addictive? Does it make you high? To put it short — no, CBD is not addictive. But let's dig deeper and learn why in our recent research. We look at the scientific proof of why CBD is not addictive. And the legislative point of view, which is also backed up by science. In our article, you can learn about the nature of addiction, and understand why we crave some things more than others. Take a look!
This document discusses issues related to drug exposed infants. It provides information on an upcoming conference on drug exposed infants including accepted learning objectives, disclosure statements, and trends in drug use during pregnancy. Specific drugs discussed include nicotine, alcohol, benzodiazepines, marijuana, stimulants, cocaine, and opiates. Information is presented on trends in neonatal abstinence syndrome, mechanisms of action and effects of various opioids including methadone and buprenorphine. The document also discusses complications of chronic opiate use for both mother and fetus, and recommendations for screening, treatment and recognizing neonatal withdrawal.
The document provides guidance for certified caregivers on safely assisting residents with medication administration. It outlines the objectives of reviewing medication policies and procedures to decrease errors. Caregivers should identify common medication errors, read physicians' orders correctly, and know potential adverse effects. Key skills include preparing one resident's medications at a time, double checking the resident and medication match each time, and giving medications within an hour of the scheduled time except for certain cases. Resident rights and reporting adverse effects are also emphasized.
This document provides information about proper use and storage of over-the-counter medicines. It discusses what medicines are, how they differ from prescription medicines, and how to choose the right over-the-counter medicine using information on the drug facts label such as active ingredients, warnings, directions for use, and expiration dates. The document stresses the importance of carefully reading labels and only taking medicines as directed.
This document provides information about proper use and storage of over-the-counter medicines. It discusses what medicines are, how they differ from prescription medicines, and how to choose the right over-the-counter medicine by reading the drug facts label. The drug facts label provides important information about active ingredients, warnings, directions for use, and when to ask a doctor before use. It emphasizes the importance of only taking recommended doses and not combining medicines without checking with a doctor or pharmacist first.
This document discusses the management of acute and chronic pain. It defines pain and describes it as a subjective experience that can be physical, psychological, emotional, or spiritual. The document then discusses the WHO analgesic ladder for treating mild, moderate, and severe pain with non-opioids, weak opioids like codeine, and strong opioids like morphine respectively. It also describes characterizing pain by duration, mechanism, origin, and situation.
Morphine and fentanyl are potent opioid analgesics that act on mu-opioid receptors in the central nervous system. Morphine is a naturally occurring substance extracted from poppy plants, while fentanyl is a synthetic opioid. Both drugs are used medicinally to treat moderate to severe pain. Common side effects include respiratory depression, nausea, constipation, and euphoria. Withdrawal from long-term opioid use can cause pain, irritability, and dysphoria.
Morphine and fentanyl are potent opioid analgesics that act on mu-opioid receptors in the central nervous system and peripheral tissues to provide pain relief. Morphine is a naturally occurring substance extracted from poppy plants, while fentanyl is a synthetic opioid. Both have a rapid onset but morphine's effects last 3-6 hours while fentanyl's last 30-60 minutes. Common side effects include respiratory depression, nausea, constipation, and euphoria. Tolerance can develop with long-term use requiring higher doses for pain management.
opioids in cancer pain manage, a case-based approach, covering
- opioid dosing and rotations
- pain assessment
- opioids adverse effects and managment thereof
- overcoming barriers to usage
This document outlines an agenda for a basic drug awareness workshop. It includes an introduction to basic drug awareness, management of drug clients, and the cycle of change model. It describes dividing attendees into groups to discuss specific drugs, including heroin, cocaine, amphetamine, benzodiazepines, cannabis, MDMA, nitrates, and nicotine. For each drug, groups will answer questions about names, type, use, effects, problems, withdrawal, and treatment of addiction. The document also discusses models of drug treatment, including harm reduction, keyworking, and assessment of drug users.
This document provides information about new psychoactive substances (NPS), also known as legal highs. It discusses where NPS come from, including head shops and online retailers, with many synthesized in China and India. It notes that new substances emerge at a rate of about one per week. The document then summarizes the effects and risks of several classes of NPS, including stimulants, hallucinogens, depressants, synthetic cannabinoids, and discusses harm reduction strategies. It concludes by providing local treatment and support resources for NPS users.
Smokeless tobacco creating the quit plan 2012 catherine whitworth and donald ...drrcpawv1
This document provides guidance on assessing smokeless tobacco dependence and developing a treatment plan. It discusses preparing for quitting, including setting a timeframe and identifying triggers. Support involves behavioral strategies and social support. Specific approaches include managing withdrawal and tapering use. Relapse is avoided by addressing cravings and replacing the habit. Medications can ease withdrawal while behavior therapies provide additional support. Herbal substitutes may help reduce nicotine intake gradually. A multicomponent approach is most effective in treating smokeless tobacco dependence.
The document discusses proper use and storage of over-the-counter medicines. It explains that medicine labels provide important information about active ingredients, uses, directions, warnings, and safety. The document emphasizes reading labels carefully and only taking medicine as directed to avoid potential side effects or dangerous interactions with other medicines.
The document discusses proper use and storage of over-the-counter medicines. It explains that medicine labels provide important information about active ingredients, uses, directions, warnings, and safety. The document emphasizes reading labels carefully and only taking medicine as directed to avoid potential side effects or dangerous interactions with other medicines.
1. The document reviews pharmacologic management in palliative care, focusing on common symptoms, medications used, and opioid management.
2. Common symptoms in terminal illness include fatigue, pain, delirium, dyspnea, nausea, depression, and insomnia. Opioids are often used off-label in palliative care based on experience rather than evidence.
3. The document provides guidance on assessing pain, converting between opioids, managing breakthrough pain and side effects, and using adjunctive medications for symptoms like nausea and dyspnea. Non-pharmacologic approaches are also emphasized.
This document discusses the financial impact of opioid abuse on employers. It identifies the primary causes of increased healthcare costs related to opioid abuse as well as simple steps employers can take to reduce risks and costs. The document explains that prescription drug abuse can impact employers even if they are not currently dealing with issues in their workplace. It provides context on the costs of chronic pain and revenue from opioids. The document examines how cultural factors led to increased opioid prescribing and abuse. It discusses challenges in predicting outcomes for different patients prescribed opioids. Finally, it outlines guiding principles for employers to address opioid abuse, including education, enforcement, oversight, and statutory action if needed.
This document discusses oxycodone, an opioid pain reliever. It lists the generic and brand names, describes how it works to relieve pain and its side effects. Potential signs of abuse are provided, such as doctor shopping or changing moods. Treatment options for addiction like buprenorphine, naltrexone and methadone are presented. Shocking statistics on overdose deaths and over-prescribing of opioids are shared, as well as a quote on the need to curb the epidemic.
This presentation discusses high-alert medications and strategies for their safe use. It begins by defining high-alert medications as those that carry a significant risk of patient harm if used in error. It then identifies the top five high-alert medication classes and provides case studies demonstrating errors. Finally, it outlines approaches like standardization, redundancy checks, and monitoring to minimize errors and their consequences for high-risk drugs. The goal is to develop policies and checklists to ensure the safest possible use of medications that require special precautions.
The document provides an overview of palliative care, including its goals, definitions, history, and differences from hospice care. Some key points:
- Palliative care focuses on improving quality of life and reducing suffering for those with serious illnesses through comprehensive pain and symptom management.
- It can begin at diagnosis and be provided alongside curative treatment.
- The WHO defines palliative care as relief from pain and symptoms, affirming life, and addressing psychological and spiritual needs.
- It aims to help patients live as actively as possible until death.
The document discusses intra and postoperative analgesia. It begins by providing background on the history of pain relief before the 19th century and the first public uses of ether as anesthesia. It then covers the anatomy and physiology of pain transmission and nociception. The bulk of the document focuses on the World Health Organization's pain ladder approach for managing pain, moving sequentially from non-opioid and weak opioid options in mild pain up to strong opioids for severe pain. Specific analgesic drugs are discussed at each step, along with adjuvant therapies and methods of administration like patient-controlled analgesia.
This presentation discusses high-alert medications, which are drugs that carry an increased risk of harming patients if used incorrectly. It identifies common classes of high-alert medications like opioids, insulin, and anticoagulants. Case scenarios are presented to demonstrate potential harms from improper use. Strategies are described for safely monitoring high-alert medications through standardization, redundancy checks, protocols, and patient monitoring to minimize risks and make errors visible.
This document summarizes New Mexico's End-of-Life Options Act, which takes effect on June 18, 2021. The act legalizes medical aid in dying, allowing terminally ill adult residents of New Mexico to request a prescription for life-ending medication from a licensed healthcare provider. To be eligible, an individual must have decision-making capacity, a terminal illness expected to cause death within 6 months, and the ability to self-administer the medication. The document outlines the qualification determination process, requirements for prescribing providers, reporting obligations, legal protections, and resources for more information.
The Legal, Insurance and Paperwork Assistance (LIPA) Program provides personalized assistance to cancer patients and survivors with applications, paperwork, bills, and referrals related to Medicaid, SNAP, SSDI and other issues. Key program elements include one-on-one appointments, referrals to additional assistance groups, and a free organizing tool to help manage cancer-related paperwork. The free program has helped over 7,000 New Mexicans coping with cancer access over $10.5 million in medical, legal, and financial benefits since 2006.
This document discusses issues related to drug exposed infants. It provides information on an upcoming conference on drug exposed infants including accepted learning objectives, disclosure statements, and trends in drug use during pregnancy. Specific drugs discussed include nicotine, alcohol, benzodiazepines, marijuana, stimulants, cocaine, and opiates. Information is presented on trends in neonatal abstinence syndrome, mechanisms of action and effects of various opioids including methadone and buprenorphine. The document also discusses complications of chronic opiate use for both mother and fetus, and recommendations for screening, treatment and recognizing neonatal withdrawal.
The document provides guidance for certified caregivers on safely assisting residents with medication administration. It outlines the objectives of reviewing medication policies and procedures to decrease errors. Caregivers should identify common medication errors, read physicians' orders correctly, and know potential adverse effects. Key skills include preparing one resident's medications at a time, double checking the resident and medication match each time, and giving medications within an hour of the scheduled time except for certain cases. Resident rights and reporting adverse effects are also emphasized.
This document provides information about proper use and storage of over-the-counter medicines. It discusses what medicines are, how they differ from prescription medicines, and how to choose the right over-the-counter medicine using information on the drug facts label such as active ingredients, warnings, directions for use, and expiration dates. The document stresses the importance of carefully reading labels and only taking medicines as directed.
This document provides information about proper use and storage of over-the-counter medicines. It discusses what medicines are, how they differ from prescription medicines, and how to choose the right over-the-counter medicine by reading the drug facts label. The drug facts label provides important information about active ingredients, warnings, directions for use, and when to ask a doctor before use. It emphasizes the importance of only taking recommended doses and not combining medicines without checking with a doctor or pharmacist first.
This document discusses the management of acute and chronic pain. It defines pain and describes it as a subjective experience that can be physical, psychological, emotional, or spiritual. The document then discusses the WHO analgesic ladder for treating mild, moderate, and severe pain with non-opioids, weak opioids like codeine, and strong opioids like morphine respectively. It also describes characterizing pain by duration, mechanism, origin, and situation.
Morphine and fentanyl are potent opioid analgesics that act on mu-opioid receptors in the central nervous system. Morphine is a naturally occurring substance extracted from poppy plants, while fentanyl is a synthetic opioid. Both drugs are used medicinally to treat moderate to severe pain. Common side effects include respiratory depression, nausea, constipation, and euphoria. Withdrawal from long-term opioid use can cause pain, irritability, and dysphoria.
Morphine and fentanyl are potent opioid analgesics that act on mu-opioid receptors in the central nervous system and peripheral tissues to provide pain relief. Morphine is a naturally occurring substance extracted from poppy plants, while fentanyl is a synthetic opioid. Both have a rapid onset but morphine's effects last 3-6 hours while fentanyl's last 30-60 minutes. Common side effects include respiratory depression, nausea, constipation, and euphoria. Tolerance can develop with long-term use requiring higher doses for pain management.
opioids in cancer pain manage, a case-based approach, covering
- opioid dosing and rotations
- pain assessment
- opioids adverse effects and managment thereof
- overcoming barriers to usage
This document outlines an agenda for a basic drug awareness workshop. It includes an introduction to basic drug awareness, management of drug clients, and the cycle of change model. It describes dividing attendees into groups to discuss specific drugs, including heroin, cocaine, amphetamine, benzodiazepines, cannabis, MDMA, nitrates, and nicotine. For each drug, groups will answer questions about names, type, use, effects, problems, withdrawal, and treatment of addiction. The document also discusses models of drug treatment, including harm reduction, keyworking, and assessment of drug users.
This document provides information about new psychoactive substances (NPS), also known as legal highs. It discusses where NPS come from, including head shops and online retailers, with many synthesized in China and India. It notes that new substances emerge at a rate of about one per week. The document then summarizes the effects and risks of several classes of NPS, including stimulants, hallucinogens, depressants, synthetic cannabinoids, and discusses harm reduction strategies. It concludes by providing local treatment and support resources for NPS users.
Smokeless tobacco creating the quit plan 2012 catherine whitworth and donald ...drrcpawv1
This document provides guidance on assessing smokeless tobacco dependence and developing a treatment plan. It discusses preparing for quitting, including setting a timeframe and identifying triggers. Support involves behavioral strategies and social support. Specific approaches include managing withdrawal and tapering use. Relapse is avoided by addressing cravings and replacing the habit. Medications can ease withdrawal while behavior therapies provide additional support. Herbal substitutes may help reduce nicotine intake gradually. A multicomponent approach is most effective in treating smokeless tobacco dependence.
The document discusses proper use and storage of over-the-counter medicines. It explains that medicine labels provide important information about active ingredients, uses, directions, warnings, and safety. The document emphasizes reading labels carefully and only taking medicine as directed to avoid potential side effects or dangerous interactions with other medicines.
The document discusses proper use and storage of over-the-counter medicines. It explains that medicine labels provide important information about active ingredients, uses, directions, warnings, and safety. The document emphasizes reading labels carefully and only taking medicine as directed to avoid potential side effects or dangerous interactions with other medicines.
1. The document reviews pharmacologic management in palliative care, focusing on common symptoms, medications used, and opioid management.
2. Common symptoms in terminal illness include fatigue, pain, delirium, dyspnea, nausea, depression, and insomnia. Opioids are often used off-label in palliative care based on experience rather than evidence.
3. The document provides guidance on assessing pain, converting between opioids, managing breakthrough pain and side effects, and using adjunctive medications for symptoms like nausea and dyspnea. Non-pharmacologic approaches are also emphasized.
This document discusses the financial impact of opioid abuse on employers. It identifies the primary causes of increased healthcare costs related to opioid abuse as well as simple steps employers can take to reduce risks and costs. The document explains that prescription drug abuse can impact employers even if they are not currently dealing with issues in their workplace. It provides context on the costs of chronic pain and revenue from opioids. The document examines how cultural factors led to increased opioid prescribing and abuse. It discusses challenges in predicting outcomes for different patients prescribed opioids. Finally, it outlines guiding principles for employers to address opioid abuse, including education, enforcement, oversight, and statutory action if needed.
This document discusses oxycodone, an opioid pain reliever. It lists the generic and brand names, describes how it works to relieve pain and its side effects. Potential signs of abuse are provided, such as doctor shopping or changing moods. Treatment options for addiction like buprenorphine, naltrexone and methadone are presented. Shocking statistics on overdose deaths and over-prescribing of opioids are shared, as well as a quote on the need to curb the epidemic.
This presentation discusses high-alert medications and strategies for their safe use. It begins by defining high-alert medications as those that carry a significant risk of patient harm if used in error. It then identifies the top five high-alert medication classes and provides case studies demonstrating errors. Finally, it outlines approaches like standardization, redundancy checks, and monitoring to minimize errors and their consequences for high-risk drugs. The goal is to develop policies and checklists to ensure the safest possible use of medications that require special precautions.
The document provides an overview of palliative care, including its goals, definitions, history, and differences from hospice care. Some key points:
- Palliative care focuses on improving quality of life and reducing suffering for those with serious illnesses through comprehensive pain and symptom management.
- It can begin at diagnosis and be provided alongside curative treatment.
- The WHO defines palliative care as relief from pain and symptoms, affirming life, and addressing psychological and spiritual needs.
- It aims to help patients live as actively as possible until death.
The document discusses intra and postoperative analgesia. It begins by providing background on the history of pain relief before the 19th century and the first public uses of ether as anesthesia. It then covers the anatomy and physiology of pain transmission and nociception. The bulk of the document focuses on the World Health Organization's pain ladder approach for managing pain, moving sequentially from non-opioid and weak opioid options in mild pain up to strong opioids for severe pain. Specific analgesic drugs are discussed at each step, along with adjuvant therapies and methods of administration like patient-controlled analgesia.
This presentation discusses high-alert medications, which are drugs that carry an increased risk of harming patients if used incorrectly. It identifies common classes of high-alert medications like opioids, insulin, and anticoagulants. Case scenarios are presented to demonstrate potential harms from improper use. Strategies are described for safely monitoring high-alert medications through standardization, redundancy checks, protocols, and patient monitoring to minimize risks and make errors visible.
Similar to Getting started with medical cannabis (20)
This document summarizes New Mexico's End-of-Life Options Act, which takes effect on June 18, 2021. The act legalizes medical aid in dying, allowing terminally ill adult residents of New Mexico to request a prescription for life-ending medication from a licensed healthcare provider. To be eligible, an individual must have decision-making capacity, a terminal illness expected to cause death within 6 months, and the ability to self-administer the medication. The document outlines the qualification determination process, requirements for prescribing providers, reporting obligations, legal protections, and resources for more information.
The Legal, Insurance and Paperwork Assistance (LIPA) Program provides personalized assistance to cancer patients and survivors with applications, paperwork, bills, and referrals related to Medicaid, SNAP, SSDI and other issues. Key program elements include one-on-one appointments, referrals to additional assistance groups, and a free organizing tool to help manage cancer-related paperwork. The free program has helped over 7,000 New Mexicans coping with cancer access over $10.5 million in medical, legal, and financial benefits since 2006.
This document provides a 5-step guide for getting started with medical cannabis. The steps are: 1) identify the primary symptom to treat, 2) determine your budget, 3) choose an appropriate delivery method such as tinctures, edibles, or inhaled products, 4) select a product containing THC, CBD, or a combination, and 5) determine your starting serving size, beginning with 2.5mg of THC or less for beginners. Safety considerations and sources for further information are also provided.
The document discusses nutrition for cancer patients during and after treatment. It recommends choosing a variety of whole foods to maintain weight and nutrition during treatment, which can help with treatment side effects and prevent cancer recurrence. Specific foods like protein, fruits and vegetables, fluids are emphasized to aid healing and provide nutrients. The document also provides tips for managing common side effects like nausea, mouth sores, taste changes, and ways to modify diets accordingly. The overall message is that eating well during and after cancer treatment is important to recovery.
This document discusses integrative oncology and the use of traditional Chinese medicine, including acupuncture, in supportive cancer care. It provides an overview of traditional Chinese medicine, how acupuncture works, common conditions it can treat in cancer patients, and research studies on its effectiveness. It also discusses Chinese herbal medicine, dietary recommendations, how to choose an acupuncturist, and cancer support therapies available at UNM Center for Life.
Patient advocacy involves preparing for appointments by requesting medical records, engaging your support system, and taking care of yourself physically and emotionally. Align expectations by asking questions of your care team, and facilitate timely access to quality care by overcoming barriers such as a lack of information or support.
The document discusses an improv medicine workshop for a cancer support conference that focuses on improving communication between doctors and patients. The workshop introduces improv medicine and has participants reflect on what they would like to be different in interactions with doctors. It discusses status behaviors in healthcare, different types of status, and increasing status awareness to improve communication and relationships between doctors and patients.
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Nano-gold for Cancer Therapy chemistry investigatory projectSIVAVINAYAKPK
chemistry investigatory project
The development of nanogold-based cancer therapy could revolutionize oncology by providing a more targeted, less invasive treatment option. This project contributes to the growing body of research aimed at harnessing nanotechnology for medical applications, paving the way for future clinical trials and potential commercial applications.
Cancer remains one of the leading causes of death worldwide, prompting the need for innovative treatment methods. Nanotechnology offers promising new approaches, including the use of gold nanoparticles (nanogold) for targeted cancer therapy. Nanogold particles possess unique physical and chemical properties that make them suitable for drug delivery, imaging, and photothermal therapy.
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...AyushGadhvi1
learning occurs when a stimulus (unconditioned stimulus) eliciting a response (unconditioned response) • is paired with another stimulus (conditioned stimulus)
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
The skin is the largest organ and its health plays a vital role among the other sense organs. The skin concerns like acne breakout, psoriasis, or anything similar along the lines, finding a qualified and experienced dermatologist becomes paramount.
7. STEP 3: DETERMINE YOUR PREFERRED DELIVERY
METHOD
• Which delivery system appeals
to you the most?
• How do you see yourself
consuming cannabis?
• Pros and cons of each type?
8. STEP 3: DETERMINE YOUR PREFERRED DELIVERY
METHOD
• Inhaled products:
• Effects are immediate
• Onset: 0-10 minute
• Lasts 1-4 hours depending on the potency
and amount consumed.
• Easy to administer around other
pharmaceuticals
9. STEP 3: DETERMINE YOUR PREFERRED DELIVERY
METHOD
• Tinctures
• 15 minutes – 1 hour to take effect
• May be taken about every 2-4 hours as
needed
• May be placed under the tongue
• Easy for micro-dosing
10. STEP 3: DETERMINE YOUR PREFERRED DELIVERY
METHOD
• Edibles
• May take 30 minutes-2 hours or longer to take
effect
• Can last anywhere from 4-10 hours
• More effective when taken with food
• Always wait at least 2 hours before taking more
12. STEP 4: CHOOSE A PRODUCT WITH THC, CBD, OR
BOTH
• THC
• Produces euphoria
• Alleviates many symptoms
• Works quickly (depending on the
delivery system and amount of THC) to
relieve a variety of symptoms.
13. STEP 4: CHOOSE THC, CBD, OR BOTH
• CBD
• Not psychoactive
• Anti-inflammatory, supports the immune system, aids in healing,
and so much more!
• Effects are more subtle than THC, and it may take 2 + weeks to
identify.
14. STEP 4: CHOOSE THC, CBD, OR BOTH
• BOTH
• THC and CBD work best when they are together!
• Combining both compounds can improve symptom relief.
• Provides balance between euphoric effects and symptom relief.
• Helps reduce side effects from THC.
16. STEP 5:
DETERMINE
YOUR SERVING
SIZE
• Individualized dosing can range from less
than 1 mg to 20+ mg.
• Beginners: 2.5 mg THC or less
• Goal is to find the smallest amount that
works!
17. STEP 5: DETERMINE YOUR SERVING SIZE
• Always understand the potency of any
products you consume.
• Read the packaging to
determine milligrams in a single serving
of an edible.
19. YOUR NOTES:
Step 1: Symptom: pain
Step 2: Budget: under $30
Step 3: Delivery method: tincture
Step 4: THC, CBD, or Both: both
Step 5: Milligrams desired: 2.5 mg to start
20. SAFETY CONSIDERATIONS
• Always wait at least 2 hours before taking an additional amount of an edible.
• Space your regular medications away from edibles by 1-2 hours. Notify
your provider if you start on a CBD product while on warfarin/coumadin.
• Never drive or operate heavy machinery while on cannabis.
• Keep away from children and pets.
• If the potency is too high, cannabis can make your symptoms worse. Simply reduce
the amount or change the form if this happens.
• Always understand the potency of any product you try! Take time to do the math.
22. TO LEARN MORE,
PLEASE VISIT US AT:
The Verdes Foundation
Albuquerque
7301 San Antonio Dr NE
Rio Rancho
2320 Grande Blvd. SE, Ste. B
www.VerdesFoundation.org
(505) 280-2814
Editor's Notes
Hello, my name is Briana Perez, and I am one of the Registered Nurses at the Verdes Foundation. New Mexico has recently approved cannabis for recreational use, so today I would like to provide you with the basic, practical steps to consider when getting started with cannabis. This is essentially a "how to guide" so I encourage you to take notes.
Number your sheet of paper from 1-5
The first thing to do is think about which symptom you would like help with. Most of us have many symptoms we are dealing with, but it is important to focus on the most problematic one. Cannabis can help many symptoms at once, but focusing on one will help you gain more insight into the effectiveness of the products you try.
Number 2: Identify your budget. Start to think about how much you would like to spend on cannabis. Cannabis is not covered by insurance, so a budget will help you select products that will be affordable and sustainable in the long-run.
Next, think about how you would like to consume cannabis. Some methods provide immediate benefits and others offer longer-lasting effects. Delivery systems can be layered to cover both immediate and longer-term needs, but in the beginning, it is best to understand how each one affects you individually before adding too many into the picture.
Think about which delivery system appeals to you the most and the least. You will not want to use a product if it is repulsive to you. In the beginning, it is important to begin with a delivery system that you feel comfortable with.
Inhaled products, such as smoking and vaporizing, are easy to use and have the fastest onset of action. You will have the most control over the amount you consume with inhaled products. They work quickly and are easy to administer around other pharmaceuticals. If you have any type of lung condition, you should check with your physician to determine if inhaled cannabis is safe for you. Vaporizing the flower is the least irritating way to inhale cannabis, because vaporizers warm the bud enough to release the oil vapor, but the plant matter does not burn.
Tinctures have the second fastest onset of action after inhaled products, and may be placed directly under the tongue. Effects begin within about 15 min to 1 hour. Tinctures are a discrete way to consume cannabis, and can deliver very small amounts of medicine at a time.
Edibles are another discrete method for consuming cannabis. They may take 30min to 2hr or longer to take effect, and can last anywhere from 4-10 hours or longer depending on the amount taken. Edibles work faster and are more effective when they are taken with food. Always wait at least 2 hours before taking an additional amount.
Step 4. Determine if you would like a product that contains THC, CBD, or both.
THC is the compound in cannabis that produces euphoria and helps alleviate a number of symptoms.
CBD is not psychoactive and can help reduce the psychoactive effects of THC. CBD has anti-inflammatory properties, supports the immune system, aids in healing, and so much more! Effects are more subtle than THC, and it may take 2 weeks or longer to identify.
THC and CBD work best when they are used together. A product that contains both compounds can provide symptom relief with minimal side effects. Products that contain both compounds are available in the inhaled forms, tinctures, and edibles.
Step 5: Determine your serving size. Everyone has different serving size needs, but there is an easy and safe method for determining the starting point that is most appropriate for you.
When you start with cannabis, it is best to start low and go slow. Read the label on the product to determine the potency of a single serving size. If you are new to cannabis, you may want to start around 2.5 mg of THC or less. It takes the body about 3-5 days to adjust to an amount of cannabis, so do not increase too quickly. The goal is to find the smallest amount that works, so you can avoid experiencing unpleasant side effects. If you do experience unpleasant side effects, your body is simply letting you know it was too much. Try reducing the serving size or potency next time you consume it, or change the delivery system if you were already at the lowest starting point for that product.
Always understand the potency of every product you consume. Each product is different, and the amounts of THC and CBD can vary significantly. It is important to read the packing carefully to determine the total potency per package and serving sizes of the product.
Now that we have discussed the different steps in finding a suitable product, lets tie it all together!
You sheet of paper should look something like this... Remember this is just a start, and anything can be modified along the way! Our dispensary has a quick start guide pamphlet that contains everything you need to know when getting started with cannabis.